Breakpoint of a balanced translocation (X:14) (q27.1;q32.3) in a girl with severe hemophilia B maps proximal to the factor IX gene

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 3, 2004, Pages 437-440

  Di Paola, Jorge ^a   Goldman, T ^a   Qian, Q ^a   Patil, S R ^a   Schute, B C ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Chromosomal translocation; Coagulation factor IX; Female with hemophilia

Indexed keywords

BLOOD CLOTTING FACTOR 9; BROXURIDINE; GENOMIC DNA; RECOMBINANT BLOOD CLOTTING FACTOR 9;

ARTICLE; AUTOSOME; CASE REPORT; CHROMOSOME 14; CHROMOSOME 14Q; CHROMOSOME ANALYSIS; CHROMOSOME BAND; CHROMOSOME INACTIVATION; CHROMOSOME REPLICATION; CHROMOSOME TRANSLOCATION X; CHROMOSOME XQ; DISEASE SEVERITY; DNA FLANKING REGION; DNA PROBE; DNA SEQUENCE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; HEMOPHILIA B; HUMAN; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PARENT; POSITION EFFECT VARIEGATION; PRESCHOOL CHILD; PRIORITY JOURNAL; X CHROMOSOME; CHILD; CHROMOSOME MAP; GENE TRANSLOCATION; GENETICS; KARYOTYPING;

CHILD; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, X; FACTOR IX; FEMALE; HEMOPHILIA B; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; TRANSLOCATION, GENETIC;

EID: 6944225415     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7933.2004.00626.x     Document Type: Article

References (15)

1. Mauser Bunschoten EP, van Houwelingen JC, Sjamsoedin Visser EJ, van Dijken PJ, Kok AJ, Sixma JJ. Bleeding symptoms in carriers of hemophilia A and B. Thromb Haemost 1988; 59: 349-52.
2. Wadelius C, Lindstedt M, Pigg M, Egberg N, Pettersson U, Anvret M. Hemophilia B in a 46,XX female probably caused by non-random X inactivation. Clin Genet 1993; 43: 1-4.
3. Chan V, Chan VW, Yip B, Chim CS, Chan TK. Hemophilia B in a female carrier due to skewed inactivation of the normal X-chromosome. Am J Hematol 1998; 58: 72-6.
4. Bithell TC, Pizarro A, MacDiarmid WD. Variant of factor IX deficiency in female with 45, X Turner's syndrome. Blood 1970; 36: 169-79.
5. Neuschatz J, Necheles TF. Hemophilia B in a phenotypically normal girl with XX (ring) XO mosaicism. Acta Haematol 1973; 49 109-13.
6. Schroder W, Poetsch M, Gazda H, Werner W, Reichelt T, Knoll W, Rokicka-Milewska R, Zieleniewska B, Herrmann FH. A de novo translocation 46,X,t(X,15) causing haemophilia B in a girl: a case report. Br J Haematol 1998; 100: 750-7.
7. Krepischi-Santos AC, Carneiro JD, Svartman M, Bendit I, Odone-Filho V, Vianna-Morgante AM. Deletion of the factor IX gene as a result of translocation t(X;1) in a girl affected by haemophilia B. Br J Haematol 2001; 113: 616-20.
8. Giddings JC. In: Thomsom JM, ed. A Practical Guide to Blood Coagulation and Hemostasis. Edimburgh: Churchill Livingstone, 1980: 117-57.
9. Lascari AD, Hoak JC, Taylor JC. Christmas disease in a girl. Am J Dis Child 1969; 117: 585-8.
10. Nisen P, Stamberg J, Ehrenpreis R, Velasco S, Shende A, Engelberg J, Karayalcin G, Waber L. The molecular basis of severe hemophilia B in a girl. N Engl J Med 1986; 315: 1139-42.
11. Taylor SA, Deugau KV, Lillicrap DP. Somatic mosaicism and female-to-female transmission in a kindred with hemophilia B (factor IX deficiency). Proc Natl Acad Sci USA 1991; 88: 39-42.
12. Schroder W, Wulff K, Wollina K, Herrmann FH. Haemophilia B in female twins caused by a point mutation in one factor IX gene and nonrandom inactivation patterns of the X-chromosomes. Thromb Haemost 1997; 78: 1347-51.
13. Waters JJ, Campbell PL, Crocker AJ, Campbell CM. Phenotypic effects of balanced X-autosome translocations in females: a retrospective survey of 104 cases reported from UK laboratories. Hum Genet 2001; 108: 318-27.
14. Driscoll MC, Dobkin CS, Alter BP. Gamma delta beta-thalassemia due to a de novo mutation deleting the 5′ beta-globin gene activation-region hypersensitive sites. Proc Natl Acad Sci USA 1989; 86: 7470-4.
15. Miao CH, Ohashi K, Patijn GA, Meuse L, Ye X, Thompson AR, Kay MA. Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro. Mol Ther 2000; 1: 522-32.